AI Insights Built for BioPharma

About BullFrog AI

BullFrog AI Holdings, Inc. (NASDAQ: BFRG) harnesses AI for pharmaceutical R&D, drug target discovery, and patient stratification, providing accelerated outputs that prioritize delivering meaningful biological insights and embedding human validation within all decisions, which lay the foundation for defensible decisions over impressive-looking weighted scorecards for pipeline and candidate selection.

Operating through three complementary capabilities:

bfPREP™ for biology-aware data harmonization

bfLEAP® for disease causal network analytics and patient subgroup discovery

bfARENAS™ for structured, auditable decision support

BullFrog AI’s platform based on proprietary technology addresses many of the major challenges in drug discovery by identifying responders vs non-responders in clinical trials, biological targets that are drivers of disease, and pipeline programs that should be prioritized over others based on targeted evidence-based, auditable answers rather than broad inference.

Resource Optimization

Built for Analytical Reliability and Processing Efficiency

When general-purpose AI tools are asked to analyze large biological datasets across many candidates in a single pass, they produce outputs with decreasing reliability as the analytical task grows more complex. bfLEAP® approaches the challenge differently by splitting analytical tasks into structured, targeted comparisons, and, by running a number of high-precision iterations that are needed to produce a stability-tested, repeatable result. The output is a reproducible, defensible finding that was generated with relevant, analytical precision and that can withstand peer review and audit.

Scientist-Led validation

Human-in-the-Loop Review and Authority

BullFrog AI uncovers findings, scientists evaluate them. Every subgroup is explained by the biological features that define it, the stability metrics that determine reproducibility upon iterations of re-analysis, and the evidence that positions it relative to known biology. The technology platform is not a black box delivering a ranked list of causal inference of disease, patient subgroups, or pipeline priorities. It is a structured analytical system delivering evidence that a scientific team can interrogate, challenge, and build upon. Scientists and Researchers stay in the driver’s seat. Our technology surfaces the signals hidden in the data that they could have otherwise missed.

Uncover the insights your data is hiding

Request a demo or feasibility assessment and discover what your data already knows.